Today: 4 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Fitch assigned a ‘BB-’ rating to senior secured notes issued by an Applied Digital subsidiary, citing both growth and credit risk. Applied Digital shares traded around $30.56 on December 5, up over 200% year-to-date, with market cap near $9 billion and a beta close to 7. The company holds $16 billion in long-term AI data-center contracts.
Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion shares rose over 10% Friday after the company reported 52-week Phase II data showing its experimental diabetes drug icovamenib sustained HbA1c reductions months after treatment ended. The results, presented at WCIRDC in Los Angeles, included no serious treatment-related adverse events. Despite the gain, Biomea’s stock remains down about 80% over the past year.
Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. shares plunged about 15% to $302 in Friday morning trading after Q3 fiscal 2026 results showed an EPS beat but missed revenue estimates. The company reported record backlog near $3.0 billion and improved margins, but analysts downgraded the stock and insiders sold over $29 million in shares in the past 90 days. Argan holds no debt and $727 million in cash.
5 December 2025
Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast shares traded at $27.81 midday Friday, up 2.2%, after the board approved the Versant Media Group spin-off. The stock remains well below its 52-week high of $43.30 and is down 13% over the past year, underperforming the S&P 500. Comcast shareholders will receive one Versant share for every 25 Comcast shares held, with the spin-off distribution set for January 2, 2026.
Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines shares jumped nearly 40% intraday on December 5 after its pivotal epilepsy trial was stopped early for efficacy and the company reported a positive pre-NDA meeting with the FDA for its essential tremor drug. By late morning, PRAX traded around $265–266, hitting a new 52-week high and pushing its market cap above $1.1 billion. The stock is up over 200% year-to-date.
MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials shares traded at $62.90 on December 5, up 1.8% after Morgan Stanley upgraded the stock to Overweight with a $71 target. The stock is down 41% from its 2025 peak near $100 but remains up over 270% year-to-date. Analyst targets mostly cluster between $70 and $80, though some models suggest fair value is closer to $46. Trading volume surged following renewed analyst optimism.
5 December 2025
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics shares closed at $10.56 on December 4, 2025, up 21%, then surged to $17.20 after hours, nearing a 52-week high. The spike came despite no new company news and follows the recent shutdown of its lead drug program and a strategic review. Market cap hovered around $10–11 million. Major shareholder Cambrian BioPharma filed to sell 21,222 shares the same day.
Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp (AKAN) Stock Soars After Shareholder Vote: Reverse Merger, Mexico Towers and 2025–2030 Forecasts

Akanda Corp shares jumped about 45% in after-hours trading Thursday to $1.37 after shareholders approved major capital changes tied to its reverse merger with First Towers & Fiber Corp. The stock had closed regular trading at $0.95, with a market cap under $1 million. Akanda, once a medical cannabis firm, now owns a telecom infrastructure business in Mexico following the August merger.
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast

SciSparc Ltd. shares closed at $1.80 on December 5, 2025, after surging on volume above 10 million, following news of a quantum bio-data analytics deal via its NeuroThera subsidiary. The stock remains down over 70% in the past year and trades more than 95% below its 52-week high of $37.59, leaving the company with a market cap near $5.8 million.
Jeffs’ Brands (JFBR) Soars on Scanary AI Security Deal: Can the Rally Last?

Jeffs’ Brands (JFBR) Soars on Scanary AI Security Deal: Can the Rally Last?

Jeffs’ Brands shares jumped 27% to $3.17 in early U.S. trading on December 5 after announcing a distribution deal for AI security scanners with Scanary Ltd. Volume surged past 20 million shares. The agreement gives Jeffs’ Brands exclusive rights in Canada, Germany, and the UAE for 24 months, with a $1 million payment to Scanary. Despite the rally, JFBR remains down over 90% year-to-date.
United States Antimony (UAMY) Stock in December 2025: Pentagon Deal, Mining Push and What Analysts Expect Next

United States Antimony (UAMY) Stock in December 2025: Pentagon Deal, Mining Push and What Analysts Expect Next

United States Antimony shares jumped 15% to close at $6.12 on December 4, 2025, after securing a Pentagon contract worth up to $245 million and a new industrial supply deal. The stock has swung between $1.06 and $19.70 over the past year. Short interest stands near 13%. Trading remains volatile, with options activity and implied volatility near 140%.
SEALSQ Corp (LAES) Stock: Quantum-Security High‑Flier After EeroQ Deal – Outlook as of December 5, 2025

SEALSQ Corp (LAES) Stock: Quantum-Security High‑Flier After EeroQ Deal – Outlook as of December 5, 2025

SEALSQ Corp (NASDAQ: LAES) shares jumped over 8% on December 4, closing near $5.08, capping a 1,000% gain over the past year. The Swiss semiconductor and security firm remains unprofitable and trades with a market cap near $0.9 billion. LAES stock has swung between $0.35 and $11.00 in the past 12 months. Volatility remains high, with daily moves often exceeding 10%.
5 December 2025
ASP Isotopes (NASDAQ: ASPI) Stock: CEO Comeback, HALEU Progress and 2026 Outlook

ASP Isotopes (NASDAQ: ASPI) Stock: CEO Comeback, HALEU Progress and 2026 Outlook

ASP Isotopes Inc. (NASDAQ: ASPI) traded near $6.70 on Friday, up sharply from earlier in the week, with a market cap around $700–730 million. The company reported just $8–9 million in revenue over the past year, heavy losses, and $113.9 million in cash as of September 30. ASP holds a 25-year Mo-100 supply deal with BRICEM in China and is developing isotope enrichment for healthcare, semiconductors, and nuclear fuels.
5 December 2025
Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

Samsara (IOT) Stock Today: Q3 FY2026 Earnings Beat, First GAAP Profit and a Wave of New $50 Price Targets

Samsara Inc. (NYSE: IOT) reported its first-ever GAAP profit and 29% revenue growth for Q3 FY2026, with revenue reaching $416 million. Shares traded around $40.71 on December 5, up 4% for the day but still 6–7% below year-to-date levels and well under the February peak. Wall Street price targets hover near $50. Market cap stands near $23.5 billion.
Inno Holdings (INHD) Stock Today: News, Forecasts and High‑Risk Opportunity in December 2025

Inno Holdings (INHD) Stock Today: News, Forecasts and High‑Risk Opportunity in December 2025

Inno Holdings Inc. (NASDAQ: INHD) traded around $0.14 per share midday December 5, 2025, down roughly 97% over the past year. The micro-cap stock has swung as much as 30% intraday and recently announced a Web3 partnership with Megabyte Solutions for a blockchain-based B2B marketplace. Market cap stands near $1.8 million, with annual revenue of $2.65 million and a net loss of $6.1 million.
5 December 2025
Hims & Hers Health (HIMS) Stock Today: Canada Expansion, Labs, GLP‑1 Growth and Fresh “Strong Buy” Call – Price, News & Forecast as of December 5, 2025

Hims & Hers Health (HIMS) Stock Today: Canada Expansion, Labs, GLP‑1 Growth and Fresh “Strong Buy” Call – Price, News & Forecast as of December 5, 2025

Hims & Hers Health shares closed at $40.02 on December 4, up nearly 8%, following a Q3 revenue jump of 49% to $599 million and guidance for Q4 revenue of $605–625 million. The company announced a $250 million buyback, two acquisitions, and a new chief policy officer. Shares remain well below the 52-week high of $72.98, with short interest elevated and volatility high.
1 527 528 529 530 531 587

Stock Market Today

  • Treasury Wine Estates Reviews Americas Operations to Enhance Returns, Shares Rise
    June 3, 2026, 9:48 PM EDT. Australia's Treasury Wine Estates announced a review of its Americas operations aimed at boosting returns and enhancing long-term shareholder value. The news triggered a share price increase of over 12% in early trading on Thursday, reflecting investor optimism about the potential operational improvements and financial gains from the review.

Latest articles

Dow Falls 620 Points After Broadcom’s After-Hours Move Shakes AI Stocks

Dow Falls 620 Points After Broadcom’s After-Hours Move Shakes AI Stocks

4 June 2026
Broadcom plunged 13.7% after hours to $413.62 as second-quarter revenue missed Wall Street estimates and its AI-chip sales forecast stayed unchanged, erasing one of the market’s last AI-linked supports just as the Dow fell 621 points and oil neared $100, stoking inflation and Fed risk concerns.
PVH Shares Drop After Results, But Quarter Wasn’t the Issue

PVH Shares Drop After Results, But Quarter Wasn’t the Issue

4 June 2026
PVH shares plunged 18.7% to $79.00 after hours as the Calvin Klein and Tommy Hilfiger owner slashed its full-year revenue outlook to roughly flat, citing ongoing pressure in Europe, the Middle East and Africa, overshadowing a first-quarter profit beat and signaling weaker second-quarter sales.
Nu Holdings Shares Fall After Analyst Downgrades and CFO Change

Nu Holdings Shares Fall After Analyst Downgrades and CFO Change

4 June 2026
Nu Holdings sank 2.43% to $11.64 after a second analyst downgrade in two days, as Susquehanna and BofA cited falling margins, rising credit risk, and uncertainty from an upcoming CFO change; credit loss allowances jumped 33% last quarter, while risk-adjusted net interest margin fell to 9.5%, raising concerns about Nu’s growth premium amid broader weakness in Brazilian bank stocks.
Intel shares snap losing streak as Wall Street eyes CPU rebound

Intel shares snap losing streak as Wall Street eyes CPU rebound

4 June 2026
Intel soared 4.43% to $112.71, snapping a five-day losing streak, after unveiling new Xeon 6+ CPUs and rack-scale AI infrastructure at Computex, positioning CPUs as central to AI buildouts and sparking renewed investor interest despite ongoing risks from rivals and rising chip costs.
Five Below Drops After Strong Quarter as Traders React

Five Below Drops After Strong Quarter as Traders React

4 June 2026
Five Below stock plunged 12.6% after hours to $194.87 despite first-quarter sales and profit beating estimates and raised full-year guidance, as investors focused on management’s warnings about rising fuel costs, sticky inflation, and a tougher consumer backdrop that could threaten the chain’s strong sales momentum.
Go toTop